technology
Open New Grounds, Thanks to Science
Essential Small Molecules such as O2, N2, H2 and CO2 embody Air Liquide’s scientific territory. These molecules have an extremely wide variety of physical and chemical properties which make them essential to life, matter and energy.
Reinforcing its focus on science for accelerating innovation, Air Liquide launched its first Scientific Challenge in 2016.
Why this challenge?
The objectives of the first Air Liquide Scientific Challenge were three-fold:
- Build a vibrant ecosystem with high level scientific partners
- Innovate for developing sustainable technologies
- Practice new ways of working through Collective Intelligence and networks
The Challenge drew people from various departments during the design phase (legal, marketing, communication, management, R&D projects).
A prestigious Jury panel included among other members Professor Jean-Marie Lehn (Nobel Prize of Chemistry 1987).
Three topics fit for the Challenge were eventually selected from quite a pool of subject matters proposed by internal experts across the company.
- How to produce hydrogen out of water using solar energy?
- How to identify sponge materials for high density storage and safe supply of gases?
- How to produce oxygen and carbon monoxide from CO2in a sustainable way?
Results
Over 100 proposals were submitted, most of them considered to be of a high level of quality.
After shortlisting a range of them, the Jury distinguished three winners, whose proposals were considered to be completely novel and promising approaches: one research team for EPFL in Lausanne (Switzerland), one research team from Nagoya University (Japan) and one research team from Université Paris-Diderot / CNRS in Paris (France).
The quality of other proposals led Air Liquide to use them for other projects. Air Liquide’s network of new potential partners has also grown.
Air Liquide launched with NineSigma its second Scientific Challenge, which closed early September 2018. Winners are to be announced in the Spring of 2019.
Other topics :
Get in touch
NineSigma Europe BV
Koning Leopold I straat 3B-3000 LeuvenBelgium
+32 16 24 42 80
europe@ninesigma.com
USE CASES
You may also like...
Pharmaceutical Industry Innovation: From ‘Core’ to ‘Tr…
The pharmaceutical industry may not have been an early adopter of open innovation (OI), yet it has made significant strides in using OI in recent years. According to research “mo…
Making Vision a Reality: Translating Foresight into Tangible…
Earlier this month we published an article, where we discussed the topic of capturing tacit knowledge to create actionable foresight – an essential starting point for shaping bus…
Active Foresight through Open Innovation: Sculpting the Futu…
For over 20 years, NineSigma has had the privilege of collaborating with innovative and renowned corporations worldwide. Our involvement in early-stage innovation projects has give…